|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 15 December 2004
doi: 10.1242/jcs.01581
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |


1 Matrix Metalloproteinase Unit, National Institute of Dental and Craniofacial Research, Bethesda, MD 20892, USA
2 Universita `La Sapienza'; Parco Scientifico Biomedico San Raffaele, 00161 Rome, Italy
3 Joint Diseases Laboratory, Shriners Hospitals for Children and Departments of Surgery, Medicine, and Cell Biology/Anatomy, Faculty of Medicine, McGill University, Montreal, Quebec, H3G 1A6, Canada
Author for correspondence (e-mail: hbhansen{at}dir.nidcr.nih.gov)
Accepted 6 October 2004
The osteocyte is the terminally differentiated state of the osteogenic mesenchymal progenitor immobilized in the bone matrix. Despite their numerical prominence, little is known about osteocytes and their formation. Osteocytes are physically separated in the bone matrix but seemingly compensate for their seclusion from other cells by maintaining an elaborate network of cell processes through which they interact with other osteocytes and bone-lining cells at the periosteal and endosteal surfaces of the bone. This highly organized architecture suggests that osteocytes make an active contribution to the structure and maintenance of their environment rather than passively submitting to random embedding during bone growth or repair. The most abundant matrix protein in the osteocyte environment is type-I collagen and we demonstrate here that, in the mouse, osteocyte phenotype and the formation of osteocyte processes is highly dependent on continuous cleavage of type-I collagen. This collagenolytic activity and formation of osteocyte processes is dependent on matrix metalloproteinase activity. Specifically, a deficiency of membrane type-1 matrix metalloproteinase leads to disruption of collagen cleavage in osteocytes and ultimately to the loss of formation of osteocyte processes. Osteocytogenesis is thus an active invasive process requiring cleavage of collagen for maintenance of the osteocyte phenotype.
Key words: Bone, Osteocytes processes, Membrane-type matrix metalloproteinase 1, MMP-13, Collagen cleavage
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
H. Zhou, W. Mak, R. Kalak, J. Street, C. Fong-Yee, Y. Zheng, C. R. Dunstan, and M. J. Seibel Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice Development, February 1, 2009; 136(3): 427 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
H K Datta, W F Ng, J A Walker, S P Tuck, and S S Varanasi The cell biology of bone metabolism J. Clin. Pathol., May 1, 2008; 61(5): 577 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Wagenaar-Miller, L. H. Engelholm, J. Gavard, S. S. Yamada, J. S. Gutkind, N. Behrendt, T. H. Bugge, and K. Holmbeck Complementary Roles of Intracellular and Pericellular Collagen Degradation Pathways In Vivo Mol. Cell. Biol., September 15, 2007; 27(18): 6309 - 6322. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Atkinson, H. M. Toennies, K. Holmbeck, and R. M. Senior Membrane type 1 matrix metalloproteinase is necessary for distal airway epithelial repair and keratinocyte growth factor receptor expression after acute injury Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L600 - L610. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Bonfil, Z. Dong, J. C. Trindade Filho, A. Sabbota, P. Osenkowski, S. Nabha, H. Yamamoto, S. R. Chinni, H. Zhao, S. Mobashery, et al. Prostate Cancer-Associated Membrane Type 1-Matrix Metalloproteinase: A Pivotal Role in Bone Response and Intraosseous Tumor Growth Am. J. Pathol., June 1, 2007; 170(6): 2100 - 2111. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Mosig, O. Dowling, A. DiFeo, M. C. M. Ramirez, I. C. Parker, E. Abe, J. Diouri, A. A. Aqeel, J. D. Wylie, S. A. Oblander, et al. Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth Hum. Mol. Genet., May 1, 2007; 16(9): 1113 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Inoue, Y. Mikuni-Takagaki, K. Oikawa, T. Itoh, M. Inada, T. Noguchi, J.-S. Park, T. Onodera, S. M. Krane, M. Noda, et al. A Crucial Role for Matrix Metalloproteinase 2 in Osteocytic Canalicular Formation and Bone Metabolism J. Biol. Chem., November 3, 2006; 281(44): 33814 - 33824. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zhang, C. Barragan-Adjemian, L. Ye, S. Kotha, M. Dallas, Y. Lu, S. Zhao, M. Harris, S. E. Harris, J. Q. Feng, et al. E11/gp38 Selective Expression in Osteocytes: Regulation by Mechanical Strain and Role in Dendrite Elongation Mol. Cell. Biol., June 15, 2006; 26(12): 4539 - 4552. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wei, M. Kashiwagi, S. Kota, Z. Xie, H. Nagase, and K. Brew Reactive Site Mutations in Tissue Inhibitor of Metalloproteinase-3 Disrupt Inhibition of Matrix Metalloproteinases but Not Tumor Necrosis Factor-{alpha}-converting Enzyme J. Biol. Chem., September 23, 2005; 280(38): 32877 - 32882. [Abstract] [Full Text] [PDF] |
||||